Pharma Mar reported EUR1.32 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q3 Sep/2025 0.28 0.22 Nov/11 2025
FY2025Q2 Jun/2025 1.32 0.01 0.07 Jul/30 2025
FY2025Q1 Mar/2025 -0.23 -0.06 0.13 Apr/28 2025
FY2024Q4 Dec/2024 0.99 -0.37 -0.37 Mar/03 2025
FY2024Q3 Sep/2024 0.22 -0.09 0.08 Nov/29 2024
FY2024Q2 Jun/2024 0.07 0.07 0.28 Aug/05 2024
FY2024Q1 Mar/2024 0.13 -0.20 0.08 Apr/30 2024
FY2023Q4 Dec/2023 -0.37 0.08 0.08 Mar/04 2024
FY2023Q3 Sep/2023 0.08 0.31 0.47 Oct/27 2023
FY2023Q2 Jun/2023 0.28 0.04 0.71 Jul/28 2023
FY2023Q1 Mar/2023 0.08 0.20 1.22 Apr/26 2023
FY2022Q4 Dec/2022 0.08 0.46 2.12 Feb/28 2023


Eps Change Date
Alaunos Therapeutics USD -0.46 0.24 Dec/2024
Almirall EUR 0.02 0.08 Jun/2025
Avita Medical USD -0.21 0.05 Dec/2024
Dianthus Therapeutics USD -0.88 0.07 Jun/2025
Ionis Pharmaceuticals USD 0.7 1.63 Jun/2025
IQVIA Holdings USD 2.81 0.11 Jun/2025
Laboratorios Farma 0.42 1.39 Jun/2025
Moderna USD -2.13 0.39 Jun/2025
Organon & Co USD 1 0.02 Jun/2025
Pharma Mar EUR 1.32 1.55 Jun/2025
Revvity USD 1.18 0.17 Jun/2025
Tectonic Therapeutic USD -1.07 0.23 Jun/2025
Viatris USD 0.62 0.12 Jun/2025
Xeris Pharmaceuticals USD -0.01 0.02 Jun/2025